{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_004525.4:c.5744A>G (N.D.)",
          "cDNA Change": {
            "transcript": "NM_004525.4",
            "ref": "A",
            "alt": "G",
            "position": "5744"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "S",
            "position": "1915"
          },
          "Description in input context": "hLRRK2(G2019S)"
        },
        {
          "HGVS": "NM_001042599.1:c.5744A>G (N.D.)",
          "cDNA Change": {
            "transcript": "NM_001042599.1",
            "ref": "A",
            "alt": "G",
            "position": "5744"
          },
          "Protein Change": {
            "ref": "I",
            "alt": "T",
            "position": "1915"
          },
          "Description in input context": "dLRRK(I1915T)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0004613"
  },
  "Experiment Method": [
    {
      "Assay Method": "Reporter gene assay",
      "Material used": {
        "Material Source": "Drosophila model",
        "Material Name": "EGFP-let-7 reporter",
        "Description": "Used an EGFP reporter system with let-7 binding sites in the 3'UTR to assess LRRK2 variant effects."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_004525.4:c.5744A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Gain-of-function",
          "Result Description": "Pathogenic hLRRK2(G2019S) increased reporter expression compared to wild-type, indicating dysregulated miRNA processing."
        },
        {
          "Variant": "NM_001042599.1:c.5744A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Gain-of-function",
          "Result Description": "Pathogenic dLRRK(I1915T) similarly increased reporter expression, linking LRRK2 kinase activity to miRNA pathway disruption."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Experiments included multiple biological replicates across developmental stages."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Fluorescence measurements were performed in triplicate for each sample."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 cDNA was used as a baseline control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector transfections served as negative controls."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA with post-hoc Tukey tests compared variant vs. control groups."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Reporter activity within 10% of wild-type levels.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Reporter activity â‰¥50% higher than wild-type baseline.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}